Cargando…
Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study
OBJECTIVE: To estimate risks of major congenital anomaly (MCA) among children of mothers prescribed antidepressants during early pregnancy or diagnosed with depression but without antidepressant prescriptions. DESIGN: Population-based cohort study. SETTING: Linked UK maternal–child primary care reco...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232879/ https://www.ncbi.nlm.nih.gov/pubmed/24612301 http://dx.doi.org/10.1111/1471-0528.12682 |
_version_ | 1782344657661853696 |
---|---|
author | Ban, L Gibson, JE West, J Fiaschi, L Sokal, R Smeeth, L Doyle, P Hubbard, RB Tata, LJ |
author_facet | Ban, L Gibson, JE West, J Fiaschi, L Sokal, R Smeeth, L Doyle, P Hubbard, RB Tata, LJ |
author_sort | Ban, L |
collection | PubMed |
description | OBJECTIVE: To estimate risks of major congenital anomaly (MCA) among children of mothers prescribed antidepressants during early pregnancy or diagnosed with depression but without antidepressant prescriptions. DESIGN: Population-based cohort study. SETTING: Linked UK maternal–child primary care records. POPULATION: A total of 349 127 singletons liveborn between 1990 and 2009. METHODS: Odds ratios adjusted for maternal sociodemographics and comorbidities (aORs) were calculated for MCAs, comparing women with first-trimester selective serotonin reuptake inhibitors (SSRIs) or tricyclic antidepressants (TCAs) and women with diagnosed but unmedicated depression, or women without diagnosed depression. MAIN OUTCOME MEASURES: Fourteen system-specific MCA groups classified according to the European Surveillance of Congenital Anomalies and five specific heart anomaly groups. RESULTS: Absolute risks of MCA were 2.7% (95% confidence interval, 95% CI, 2.6–2.8%) in children of mothers without diagnosed depression, 2.8% (95% CI 2.5–3.2%) in children of mothers with unmedicated depression, and 2.7% (95% CI 2.2–3.2%) and 3.1% (95% CI 2.2–4.1%) in children of mothers with SSRIs or TCAs, respectively. Compared with women without depression, MCA overall was not associated with unmedicated depression (aOR 1.07, 95% CI 0.96–1.18), SSRIs (aOR 1.01, 95% CI 0.88–1.17), or TCAs (aOR 1.09, 95% CI 0.87–1.38). Paroxetine was associated with increased heart anomalies (absolute risk 1.4% in the exposed group compared with 0.8% in women without depression; aOR 1.78, 95% CI 1.09–2.88), which decreased marginally when compared with women with diagnosed but unmedicated depression (aOR 1.67, 95% CI 1.00–2.80). CONCLUSIONS: Overall MCA risk did not increase with maternal depression or with antidepressant prescriptions. Paroxetine was associated with increases of heart anomalies, although this could represent a chance finding from a large number of comparisons undertaken. |
format | Online Article Text |
id | pubmed-4232879 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BlackWell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-42328792014-12-15 Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study Ban, L Gibson, JE West, J Fiaschi, L Sokal, R Smeeth, L Doyle, P Hubbard, RB Tata, LJ BJOG Epidemiology OBJECTIVE: To estimate risks of major congenital anomaly (MCA) among children of mothers prescribed antidepressants during early pregnancy or diagnosed with depression but without antidepressant prescriptions. DESIGN: Population-based cohort study. SETTING: Linked UK maternal–child primary care records. POPULATION: A total of 349 127 singletons liveborn between 1990 and 2009. METHODS: Odds ratios adjusted for maternal sociodemographics and comorbidities (aORs) were calculated for MCAs, comparing women with first-trimester selective serotonin reuptake inhibitors (SSRIs) or tricyclic antidepressants (TCAs) and women with diagnosed but unmedicated depression, or women without diagnosed depression. MAIN OUTCOME MEASURES: Fourteen system-specific MCA groups classified according to the European Surveillance of Congenital Anomalies and five specific heart anomaly groups. RESULTS: Absolute risks of MCA were 2.7% (95% confidence interval, 95% CI, 2.6–2.8%) in children of mothers without diagnosed depression, 2.8% (95% CI 2.5–3.2%) in children of mothers with unmedicated depression, and 2.7% (95% CI 2.2–3.2%) and 3.1% (95% CI 2.2–4.1%) in children of mothers with SSRIs or TCAs, respectively. Compared with women without depression, MCA overall was not associated with unmedicated depression (aOR 1.07, 95% CI 0.96–1.18), SSRIs (aOR 1.01, 95% CI 0.88–1.17), or TCAs (aOR 1.09, 95% CI 0.87–1.38). Paroxetine was associated with increased heart anomalies (absolute risk 1.4% in the exposed group compared with 0.8% in women without depression; aOR 1.78, 95% CI 1.09–2.88), which decreased marginally when compared with women with diagnosed but unmedicated depression (aOR 1.67, 95% CI 1.00–2.80). CONCLUSIONS: Overall MCA risk did not increase with maternal depression or with antidepressant prescriptions. Paroxetine was associated with increases of heart anomalies, although this could represent a chance finding from a large number of comparisons undertaken. BlackWell Publishing Ltd 2014-11 2014-03-11 /pmc/articles/PMC4232879/ /pubmed/24612301 http://dx.doi.org/10.1111/1471-0528.12682 Text en © 2014 The Authors. BJOG An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd on behalf of Royal College of Obstetricians and Gynaecologists. http://creativecommons.org/licenses/by/3.0/ This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Epidemiology Ban, L Gibson, JE West, J Fiaschi, L Sokal, R Smeeth, L Doyle, P Hubbard, RB Tata, LJ Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study |
title | Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study |
title_full | Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study |
title_fullStr | Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study |
title_full_unstemmed | Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study |
title_short | Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study |
title_sort | maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study |
topic | Epidemiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232879/ https://www.ncbi.nlm.nih.gov/pubmed/24612301 http://dx.doi.org/10.1111/1471-0528.12682 |
work_keys_str_mv | AT banl maternaldepressionantidepressantprescriptionsandcongenitalanomalyriskinoffspringapopulationbasedcohortstudy AT gibsonje maternaldepressionantidepressantprescriptionsandcongenitalanomalyriskinoffspringapopulationbasedcohortstudy AT westj maternaldepressionantidepressantprescriptionsandcongenitalanomalyriskinoffspringapopulationbasedcohortstudy AT fiaschil maternaldepressionantidepressantprescriptionsandcongenitalanomalyriskinoffspringapopulationbasedcohortstudy AT sokalr maternaldepressionantidepressantprescriptionsandcongenitalanomalyriskinoffspringapopulationbasedcohortstudy AT smeethl maternaldepressionantidepressantprescriptionsandcongenitalanomalyriskinoffspringapopulationbasedcohortstudy AT doylep maternaldepressionantidepressantprescriptionsandcongenitalanomalyriskinoffspringapopulationbasedcohortstudy AT hubbardrb maternaldepressionantidepressantprescriptionsandcongenitalanomalyriskinoffspringapopulationbasedcohortstudy AT tatalj maternaldepressionantidepressantprescriptionsandcongenitalanomalyriskinoffspringapopulationbasedcohortstudy |